drug
fentanyl ER
Marketedupdated 3mo agoby Actavis Elizabeth LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval674 co-mentions · 246 sources
- drugfentanyl CR641 co-mentions · 294 sources
- drugFENTANYL-75641 co-mentions · 294 sources
- drugfentanyl641 co-mentions · 294 sources
- drugFENTANYL-37641 co-mentions · 294 sources
- drugActiq240 co-mentions · 183 sources
- drugSUBLIMAZE PRESERVATIVE FREE238 co-mentions · 183 sources
- drugEffentora234 co-mentions · 183 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 30 investigational indications.
all catalysts(54)
approval · 51
Jan 28, 2005
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
May 4, 2005
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Sep 6, 2005
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Jan 23, 2007
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Jan 23, 2007
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
May 20, 2008
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Feb 9, 2011
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Jul 9, 2012
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Jul 9, 2012
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Jul 9, 2012
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Jul 9, 2012
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Jul 10, 2012
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Apr 15, 2013
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Apr 15, 2013
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Jun 16, 2014
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Jun 20, 2014
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Aug 19, 2014
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Aug 19, 2014
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Jun 11, 2015
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Jun 26, 2015
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Jun 26, 2015
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Jul 8, 2015
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Apr 20, 2016
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Apr 20, 2016
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Sep 30, 2016
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Sep 30, 2016
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
May 26, 2017
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
May 26, 2017
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Sep 18, 2018
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Sep 18, 2018
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
May 6, 2020
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
May 6, 2020
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
May 6, 2020
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
May 6, 2020
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
May 6, 2020
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 8, 2023
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 14, 2023
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 14, 2023
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 14, 2023
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 14, 2023
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 14, 2023
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 15, 2023
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 15, 2023
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 15, 2023
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Oct 31, 2024
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Oct 31, 2024
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 22, 2025
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 22, 2025
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 22, 2025
approval
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 22, 2025
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 22, 2025
approval
$NIU2.0500-2.84%
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
phase 2 completion · 2
Trials studying fentanyl ER
- phase2A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade
- N/AIntercostal Nerve Cryoablation Versus Epidural Analgesia for Nuss Repair of Pectus Excavatum
- phase4Premedication for Less Invasive Surfactant Administration Study (PRELISA)
- phase1A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors
- phase1Buprenorphine-Fentanyl Interaction Study
- phase1Bioequivalence Study of Fentanyl Transdermal System (JNJ-35685-AAA-G021) Compared With DURAGESIC Fentanyl Transdermal Patch in Healthy Participants
- phase1A Study to Evaluate the Adherence of 2 Strengths of Newly Manufactured Samples and Aged Samples of a New Formulation (JNJ-35685-AAA-G016 and JNJ-35685-AAA-G021) of Fentanyl Transdermal System Compared With Duragesic Fentanyl Transdermal Patch in Healthy Participants
- phase4Programmed Intermittent Epidural Bolus (PIEB) Techniques for Labour Analgesia
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 25, 2027
163 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (68)
- Apr 27, 2030formulationUS 84869723.7y
- Apr 27, 2030formulationUS 84869723.7y
- Apr 27, 2030formulationUS 84869723.7y
- Apr 27, 2030formulationUS 84869723.7y
- Apr 27, 2030formulationUS 84869723.7y
- Apr 27, 2030formulationUS 84869723.7y
- Apr 27, 2030formulationUS 84869723.7y
- Apr 27, 2030method-of-use (U-55)US 84869733.7y
- Apr 27, 2030method-of-use (U-55)US 84869733.7y
- Apr 27, 2030method-of-use (U-55)US 84869733.7y
- Apr 27, 2030method-of-use (U-55)US 84869733.7y
- Apr 27, 2030method-of-use (U-55)US 84869733.7y
- Apr 27, 2030method-of-use (U-55)US 84869733.7y
- Apr 27, 2030method-of-use (U-55)US 84869733.7y
- Jan 25, 2027formulationUS 10016403163d
- Jan 25, 2027formulationUS 10016403163d
- Jan 25, 2027formulationUS 10016403163d
- Jan 25, 2027formulationUS 10016403163d
- Jan 25, 2027formulationUS 10016403163d
- Jan 25, 2027formulationUS 10016403163d
- Jan 25, 2027formulationUS 10016403163d
- Jan 25, 2027formulationUS 10610523163d
- Jan 25, 2027formulationUS 10610523163d
- Jan 25, 2027formulationUS 10610523163d
- Jan 25, 2027formulationUS 10610523163d
- Jan 25, 2027formulationUS 10610523163d
- Jan 25, 2027formulationUS 10610523163d
- Jan 25, 2027formulationUS 10610523163d
- Jan 25, 2027formulationUS 8835459163d
- Jan 25, 2027formulationUS 8835459163d
- Jan 25, 2027formulationUS 8835459163d
- Jan 25, 2027formulationUS 8835459163d
- Jan 25, 2027formulationUS 8835459163d
- Jan 25, 2027formulationUS 8835460163d
- Jan 25, 2027formulationUS 8835460163d
- Jan 25, 2027formulationUS 8835460163d
- Jan 25, 2027formulationUS 8835460163d
- Jan 25, 2027formulationUS 8835460163d
- Jan 25, 2027formulationUS 8835460163d
- Jan 25, 2027formulationUS 8835460163d
- Jan 25, 2027formulationUS 9241935163d
- Jan 25, 2027formulationUS 9241935163d
- Jan 25, 2027formulationUS 9241935163d
- Jan 25, 2027formulationUS 9241935163d
- Jan 25, 2027formulationUS 9241935163d
- Jan 25, 2027formulationUS 9241935163d
- Jan 25, 2027formulationUS 9241935163d
- Jan 25, 2027formulationUS 9289387163d
- Jan 25, 2027formulationUS 9289387163d
- Jan 25, 2027formulationUS 9289387163d
- Jan 25, 2027formulationUS 9289387163d
- Jan 25, 2027formulationUS 9289387163d
- Jan 25, 2027formulationUS 9289387163d
- Jan 25, 2027formulationUS 9289387163d
- Jan 25, 2027formulationUS 9642797163d
- Jan 25, 2027formulationUS 9642797163d
- Jan 25, 2027formulationUS 9642797163d
- Jan 25, 2027formulationUS 9642797163d
- Jan 25, 2027formulationUS 9642797163d
- Jan 25, 2027formulationUS 9642797163d
- Jan 25, 2027formulationUS 9642797163d
- Jan 25, 2027formulationUS 9642844163d
- Jan 25, 2027formulationUS 9642844163d
- Jan 25, 2027formulationUS 9642844163d
- Jan 25, 2027formulationUS 9642844163d
- Jan 25, 2027formulationUS 9642844163d
- Jan 25, 2027formulationUS 9642844163d
- Jan 25, 2027formulationUS 9642844163d
News(10)
- Two years after rules overhaul, have methadone clinics really changed?Methadone clinics don't have to be as rigid in how they dispense opioid addiction medicine. Some, though not all, are changing their ways.stat · 12h ago
- Syphilis spreads while researchers contend with federal constraints and a drug shortageAt the San Diego-Tijuana border, syphilis spreads while researchers contend with federal constraints and a drug shortage.stat · 14d ago
- Anthony Fauci’s pandemic-era diary entriesNew data on American substance use, concerns of a global HIV resurgence, and more health news from Morning Roundsstat · 17d ago
- Opinion: The shortage of forensic pathologists is hurting justice, public health, and familiesIt’s time to solve the case of the missing pathologist.stat · 1mo ago
- Six of the biggest health news stories todayHigh-end infant formula scrutiny, the spread of synthetic opioids, and more health news from Morning Roundsstat · 1mo ago
- Super-potent synthetic opioids called nitazenes are spreading across the U.S.Overdose deaths confirmed to involve nitazenes have risen sharply in the U.S., from 27 in 2020 to 409 in 2024, according to the CDCstat · 1mo ago
- New infant botulism outbreak puts fancy formulas under scrutinyA new infant botulism outbreak puts fancy formulas that position their products as safer than other options under scrutiny.stat · 1mo ago
- RFK Jr. presents $700 million in mental health funding, but experts say grants aren’t newRFK Jr. presents funding intended to address mental illness and addiction, particularly among homeless people.stat · 1mo ago
- FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid OverdoseThe U.S. Food and Drug Administration (FDA) today approved another over-the-counter (OTC) intranasal naloxone product, Rextovy, a 4 milligram (mg) naloxone hydrochloride nasal spray for the emergen…fda_press · 1mo ago
- Why isn’t alcohol seen as a public health emergency?Why isn't alcohol seen as a public health emergency? Alex Hogan talks to STAT's Isabella Cueto and Lev Facher about their new series on this week's STATus Report.stat · 3mo ago
Data sources
last refreshed 21m ago
Found something off?
comments(0)
5-min edit window · permanent after that